Reply: risk factors for disease progression in fibrotic hypersensitivity pneumonitis. Farooqi MM, Hambly N, Ryerson CJ, Kolb M, et al. Eur Respir J 2022 Dec 22:2202261. doi: 10.1183/13993003.02261-2022.

Read + Share

Amedeo Smart

Independent Medical Education

Farooqi MM, Hambly N, Ryerson CJ, Kolb M, et al. Reply: risk factors for disease progression in fibrotic hypersensitivity pneumonitis. Eur Respir J 2022 Dec 22:2202261. doi: 10.1183/13993003.02261-2022.
PMID: 36549715